ALEXANDRIA, Va., June 4 -- United States Patent no. 12,320,798, issued on June 3, was assigned to Metabolon Inc. (Morrisville, N.C.).
"Diagnostic methods, therapeutic agents and uses thereof" was invented by Luke Miller (Bahama, N.C.), Klaus Peter Adam (Cary, N.C.), Michael V. Milburn (Cary, N.C.), Jeffery E. Cobb (Chapel Hill, N.C.), Anne M. Evans (Cary, N.C.) and Qibo Zhang (Cary, N.C.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a method for diagnosing a disease or disorder selected from the group consisting of insulin resistance, a metabolic disorder, diabetes and pre-diabetes in a subject. The method comprises the step of determining the level of a compound represented b...